Staphylococcus haemolyticus

Staphylococcus haemolyticus is a significant coagulase-negative member of the Staphylococcus genus, first described by Friedrich Julius Rosenbach in 1884. It is a Gram-positive, facultatively anaerobic coccus that forms part of the normal human skin flora but has emerged as a formidable opportunistic pathogen, particularly in healthcare settings. Its clinical importance is primarily driven by its capacity to cause serious infections in immunocompromised patients and its notorious propensity for developing multidrug resistance, including to last-resort antibiotics.

Description and taxonomy

This bacterium is a non-motile, catalase-positive coccus that typically appears in grape-like clusters under microscopic examination. It is distinguished from the more virulent Staphylococcus aureus by being coagulase-negative, a key test in the clinical laboratory. Taxonomically, it belongs to the family Staphylococcaceae within the order Bacillales. The species name "haemolyticus" refers to its characteristic beta-hemolytic activity on blood agar plates, where it produces clear zones of hemolysis around colonies, a trait it shares with some strains of Staphylococcus aureus. Its cell wall structure and genetic makeup have been extensively studied through techniques like multilocus sequence typing and whole-genome sequencing, revealing considerable genomic plasticity.

Pathogenesis and virulence factors

While traditionally considered less virulent than Staphylococcus aureus, it possesses an arsenal of factors that facilitate colonization and infection. A primary virulence attribute is its ability to form robust biofilms on implanted medical devices, such as central venous catheters and prosthetic heart valves, which protect the bacterial community from host immune defenses and antibiotics. It produces various surface adhesins that mediate attachment to host extracellular matrix proteins like fibronectin and fibrinogen. Additionally, it secretes several potential toxins and enzymes, including hemolysins that lyse red blood cells, lipases, and proteases that may contribute to tissue damage and nutrient acquisition. The regulation of these factors is complex and influenced by quorum-sensing systems similar to the agr system found in other staphylococci.

Clinical significance and infections

It is a leading cause of nosocomial bloodstream infections, particularly catheter-related bacteremia and septicemia in critically ill patients in intensive care units. Other significant infections include endocarditis associated with prosthetic valves, ventriculoperitoneal shunt infections, peritonitis in patients on continuous ambulatory peritoneal dialysis, urinary tract infections, and infections of surgical sites and prosthetic joints. Its role in neonatal sepsis and infections in patients with hematological malignancies or severe burns is also well-documented. The clinical course can be indolent but persistent, often linked to the presence of a colonized foreign body.

Antimicrobial resistance

This species is notorious for its rapid acquisition of antimicrobial resistance, often exhibiting multidrug-resistant (MDR) or extensively drug-resistant (XDR) profiles. A hallmark is its frequent resistance to methicillin, mediated by the acquisition of the mecA gene carried on a mobile genetic element called the staphylococcal cassette chromosome mec (SCCmec). Many clinical isolates show high-level resistance to macrolides, aminoglycosides, and fluoroquinolones. Alarmingly, resistance to glycopeptide antibiotics like vancomycin—a key therapeutic agent—has been reported, with strains exhibiting reduced susceptibility (VISA-like phenotypes) or, more rarely, full resistance via the vanA gene cluster, a trait likely acquired from Enterococcus faecalis. This resistance panorama severely limits treatment options, sometimes necessitating the use of newer agents like daptomycin or linezolid.

Laboratory identification

Initial identification from clinical specimens relies on colony morphology on blood agar, Gram stain, and standard biochemical tests. Automated systems like the VITEK 2 or BD Phoenix are commonly used in clinical microbiology laboratories. Definitive species-level identification often requires additional methods to differentiate it from other coagulase-negative staphylococci, such as Staphylococcus epidermidis. These methods include matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), which provides rapid and accurate identification. Phenotypic tests for novobiocin susceptibility (it is resistant) and the absence of pyrrolidonyl arylamidase activity can also be supportive. Antimicrobial susceptibility testing, guided by standards from the Clinical and Laboratory Standards Institute, is critical given its resistance patterns.

Epidemiology and transmission

It is a ubiquitous commensal, predominantly colonizing the axillae, perineum, and inguinal areas of humans. In the hospital environment, it is a major cause of device-associated infections, with transmission occurring primarily via the hands of healthcare workers. Outbreaks have been traced to contaminated environmental surfaces and medical equipment. Patients in the intensive care unit, those with indwelling devices, and individuals who have undergone major surgery or who are receiving broad-spectrum antibiotics are at highest risk for infection. The epidemiology is complicated by the global spread of specific multidrug-resistant clones, which can be tracked using molecular typing methods like pulsed-field gel electrophoresis and whole-genome sequencing. Category:Bacteria Category:Gram-positive bacteria